Although YAP usually functions as an oncogene, abundant literature supports the idea that YAP functions as a tumour suppressor in various cancers, for instance head and neck cancers (HNC) [116], breast cancer [117–119], haematological cancers [120], and CRC [121]. Here, YAP1 is linked to breast cancer.